PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,638,128 | -26.8% | 53,394 | -4.4% | 0.00% | 0.0% |
| Q2 2023 | $2,237,869 | -0.6% | 55,849 | +1.2% | 0.00% | 0.0% |
| Q1 2023 | $2,251,651 | +7.7% | 55,174 | +1.9% | 0.00% | 0.0% |
| Q4 2022 | $2,090,926 | -16.5% | 54,155 | +15.1% | 0.00% | -33.3% |
| Q3 2022 | $2,504,000 | -5.4% | 47,060 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $2,646,000 | -32.6% | 45,382 | -11.8% | 0.00% | 0.0% |
| Q1 2022 | $3,928,000 | +46.0% | 51,473 | +15.1% | 0.00% | +200.0% |
| Q4 2021 | $2,690,000 | -25.8% | 44,723 | -30.9% | 0.00% | -50.0% |
| Q3 2021 | $3,623,000 | +15.6% | 64,688 | +25.3% | 0.00% | 0.0% |
| Q2 2021 | $3,135,000 | -4.8% | 51,644 | +9.9% | 0.00% | 0.0% |
| Q1 2021 | $3,292,000 | -19.1% | 46,983 | -30.9% | 0.00% | 0.0% |
| Q4 2020 | $4,067,000 | +69.2% | 67,976 | +70.1% | 0.00% | +100.0% |
| Q3 2020 | $2,403,000 | -37.6% | 39,967 | -45.5% | 0.00% | -66.7% |
| Q2 2020 | $3,850,000 | +26.1% | 73,359 | -19.4% | 0.00% | 0.0% |
| Q1 2020 | $3,053,000 | -31.6% | 91,029 | -7.6% | 0.00% | 0.0% |
| Q4 2019 | $4,462,000 | +236.2% | 98,487 | +182.5% | 0.00% | +200.0% |
| Q3 2019 | $1,327,000 | -60.4% | 34,861 | -54.8% | 0.00% | -66.7% |
| Q2 2019 | $3,355,000 | -33.5% | 77,142 | -41.8% | 0.00% | -40.0% |
| Q1 2019 | $5,044,000 | +219.0% | 132,517 | +260.7% | 0.01% | +150.0% |
| Q4 2018 | $1,581,000 | -13.2% | 36,739 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $1,821,000 | +37.1% | 37,051 | -10.6% | 0.00% | +100.0% |
| Q2 2018 | $1,328,000 | -5.1% | 41,441 | -7.7% | 0.00% | 0.0% |
| Q1 2018 | $1,399,000 | -58.5% | 44,898 | -39.2% | 0.00% | -66.7% |
| Q4 2017 | $3,373,000 | +106.2% | 73,873 | +69.6% | 0.00% | +50.0% |
| Q3 2017 | $1,636,000 | +39.0% | 43,563 | +76.4% | 0.00% | +100.0% |
| Q2 2017 | $1,177,000 | +15.4% | 24,689 | +10.3% | 0.00% | 0.0% |
| Q1 2017 | $1,020,000 | -76.9% | 22,378 | -83.6% | 0.00% | -75.0% |
| Q4 2016 | $4,409,000 | +98.1% | 136,486 | +109.8% | 0.00% | +100.0% |
| Q3 2016 | $2,226,000 | -25.0% | 65,069 | -26.1% | 0.00% | -33.3% |
| Q2 2016 | $2,967,000 | +85.4% | 87,994 | +191.3% | 0.00% | +50.0% |
| Q1 2016 | $1,600,000 | -58.9% | 30,206 | -40.5% | 0.00% | -50.0% |
| Q4 2015 | $3,897,000 | +140.4% | 50,733 | +28.7% | 0.00% | +100.0% |
| Q3 2015 | $1,621,000 | -63.6% | 39,428 | -37.4% | 0.00% | -50.0% |
| Q2 2015 | $4,452,000 | +67.5% | 62,950 | +110.4% | 0.00% | +33.3% |
| Q1 2015 | $2,658,000 | -39.3% | 29,919 | -39.4% | 0.00% | -25.0% |
| Q4 2014 | $4,377,000 | +33.2% | 49,378 | +45.7% | 0.00% | +33.3% |
| Q3 2014 | $3,286,000 | +9.8% | 33,896 | +4.0% | 0.00% | +50.0% |
| Q2 2014 | $2,993,000 | +81.2% | 32,578 | +38.1% | 0.00% | 0.0% |
| Q1 2014 | $1,652,000 | -54.6% | 23,594 | -62.7% | 0.00% | -33.3% |
| Q4 2013 | $3,638,000 | +136.7% | 63,283 | +97.9% | 0.00% | +50.0% |
| Q3 2013 | $1,537,000 | +117.7% | 31,980 | +31.3% | 0.00% | +100.0% |
| Q2 2013 | $706,000 | +133.8% | 24,361 | +133.0% | 0.00% | – |
| Q1 2013 | $302,000 | – | 10,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |